Axe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, G1V 4G2, QC, Canada.
Institute for Experimental Immunology and Imaging, University Hospital Essen, University of Duisburg-Essen, Essen, D-45141, Germany.
Nat Commun. 2022 Oct 2;13(1):5786. doi: 10.1038/s41467-022-33463-x.
Spinal cord injury (SCI) triggers neuroinflammation, and subsequently secondary degeneration and oligodendrocyte (OL) death. We report that the alarmin interleukin (IL)-1α is produced by damaged microglia after SCI. Intra-cisterna magna injection of IL-1α in mice rapidly induces neutrophil infiltration and OL death throughout the spinal cord, mimicking the injury cascade seen in SCI sites. These effects are abolished through co-treatment with the IL-1R1 antagonist anakinra, as well as in IL-1R1-knockout mice which demonstrate enhanced locomotor recovery after SCI. Conditional restoration of IL-1R1 expression in astrocytes or endothelial cells (ECs), but not in OLs or microglia, restores IL-1α-induced effects, while astrocyte- or EC-specific Il1r1 deletion reduces OL loss. Conditioned medium derived from IL-1α-stimulated astrocytes results in toxicity for OLs; further, IL-1α-stimulated astrocytes generate reactive oxygen species (ROS), and blocking ROS production in IL-1α-treated or SCI mice prevented OL loss. Thus, after SCI, microglia release IL-1α, inducing astrocyte- and EC-mediated OL degeneration.
脊髓损伤 (SCI) 会引发神经炎症,进而导致继发性退化和少突胶质细胞 (OL) 死亡。我们报告称,受损的小胶质细胞在 SCI 后会产生警报素白细胞介素 (IL)-1α。在小鼠的脑脊髓腔中注射 IL-1α 会迅速诱导中性粒细胞浸润和整个脊髓中的 OL 死亡,模拟 SCI 部位所见的损伤级联反应。这些影响可以通过与 IL-1R1 拮抗剂 anakinra 共同治疗或在 IL-1R1 敲除小鼠中消除,后者在 SCI 后表现出运动功能恢复增强。在星形胶质细胞或内皮细胞 (EC) 中条件性恢复 IL-1R1 表达,但不在 OL 或小胶质细胞中恢复,会恢复 IL-1α 诱导的作用,而星形胶质细胞或 EC 特异性 Il1r1 缺失会减少 OL 丢失。由 IL-1α 刺激的星形胶质细胞产生的条件培养基会导致 OL 毒性;此外,IL-1α 刺激的星形胶质细胞会产生活性氧物种 (ROS),并阻止 IL-1α 处理或 SCI 小鼠中的 ROS 产生可防止 OL 丢失。因此,SCI 后,小胶质细胞释放 IL-1α,诱导星形胶质细胞和 EC 介导的 OL 退化。
Mol Neurodegener. 2016-2-3
Eur Rev Med Pharmacol Sci. 2019-3
Signal Transduct Target Ther. 2025-8-20
Neuron. 2025-1-8
CNS Neurosci Ther. 2024-12
J Nanobiotechnology. 2024-12-19
Nat Neurosci. 2021-3
Nat Commun. 2020-9-29
Cell Rep. 2020-6-23
Nat Commun. 2020-6-2